Pure mucinous carcinoma with micropapillary pattern · Pure mucinous carcinoma · Invasive micropapillary carcinoma · Mammary tumor · Surgery Abstract Pure mucinous breast carcinoma with micropapillary pattern (MUMPC) was proposed as a new histopathological variant of pure mucinous carcinoma (PMC) with tumor cells forming a micropapillary architecture. The Classification of Tumours of the Breast by the World Health Organization, however, does not differentiate MUMPC as a distinct subtype. There is currently no consensus whether tumors that exhibit these features are classified as PMC or invasive micropapillary carcinoma (IMPC) with associated mucin production. A 45-year-old woman was examined for a tumor in her left breast. Upon physical examination, an elastic hard mass of around 5 cm along with accompanying skin flare and ulceration was palpated in the upper outer quadrant of the left breast. Mammary ultrasonography revealed a clearly marginated hypoechoic tumor of 55.0 × 46.9 × 37.0 mm in size in the upper outer quadrant of the left breast. A vacuum-assisted biopsy (VAB) was performed in the same site and histopathological diagnosis of PMC was made. Contrast-enhanced magnetic resonance imaging (MRI) showed a T1W1 low-intensity signal and a T2W1 high-intensity signal at the primary focus, ring enhancement of the tumor margin, and stranding enhancement inside the tumor. A preoperative Case
. The Classification of Tumours of the Breast by the World Health Organization (2012), however, does not differentiate MUMPC as a distinct subtype [2] . There is currently no consensus whether tumors that exhibit these features are classified as PMC or invasive micropapillary carcinoma (IMPC) with associated mucin production. For this reason, although MUMPC shows pathological characteristics suggestive of PMC, reports suggest that biologically it should be considered as IMPC [3] [4] [5] [6] . Here, we have reported a case of MUMPC along with a review of the literature.
Case Presentation
A 45-year-old woman was examined for a tumor in her left breast. The patient had no significant and relevant medical or family history. Upon physical examination, an elastic hard mass of around 5 cm along with accompanying skin flare and ulceration was palpated in the upper outer quadrant of the left breast (Fig. 1a) . Multiple lymph nodes in the left axilla were also palpable. Mammary ultrasonography revealed a clearly marginated hypoechoic tumor of 55.0 × 46.9 × 37.0 mm in size in the upper outer quadrant of the left breast (Fig. 1b) . A vacuumassisted biopsy (VAB) was performed in the same site and histopathological diagnosis of PMC was made (Fig. 1c) . The immunohistochemical staining revealed a strongly positive diffused expression of estrogen receptor (ER) and progesterone receptor (PgR), negative expression of human epidermal growth factor receptor 2 (HER2), and high expression of Ki-67. Computed tomography (CT) exhibited no distant metastases, although axillary lymph node metastases were suspected. Contrast-enhanced magnetic resonance imaging (MRI) showed a T1W1 lowintensity signal and a T2W1 high-intensity signal at the primary focus, ring enhancement of the tumor margin, and stranding enhancement inside the tumor (Fig. 2a, b) . Bone scintigraphy also revealed no bone metastasis. A preoperative diagnosis of left breast cancer (PMC), cT4bN1M0, stage IIIB, luminal B-like was made.
We performed a simple mastectomy with axillary lymph node dissection. A 55.0 × 48.1 × 37.1 mm tumor with the gelatinous cut surface was excised (Fig. 3a) . Histopathological examination of the excised specimen revealed mucin lake formation in the tumor containing clusters of atypical cells (Fig. 3b) . The atypical cells showed swollen, irregular nuclei and a papillary growth pattern that lead to the diagnosis of MUMPC. The expression of ER and PgR were diffused and strongly positive, HER2 expression was negative, and Ki-67 expression was high. Based on these findings, the final diagnosis of left breast cancer (MUMPC), pT3N0M0, stage IIB, luminal B-like was made. Adjuvant chemotherapy was initiated after the surgery (adriamycin and cyclophosphamide [AC] followed by weekly paclitaxel) [7, 8] and an endocrine therapy was planned (tamoxifen 20 mg/day) [9] . No metastatic recurrence has occurred until the time of drafting this case report, 3 months after the surgery.
Discussion/Conclusion
MUMPC is a rare histopathological variant of breast cancer that reportedly accounts for < 1% of all breast cancers [1] and 12-35% of all PMC cases [3, 10] . Nevertheless, there is no consensus whether MUMPC should be considered as a subtype of PMC or IMPC [2] .
PMC is reported to account for approximate 2-3% of all breast cancers, ≥90% of all cancers that exhibit infiltration associated with mucous secretion [2, 11] , and histopathologically it has a favorable prognosis [12, 13] . On the other hand, IMPC is a distinct subtype of invasive ductal breast cancer having histopathological characteristics of a micropapillary structure and was first reported by Siriaunkgul and Tavassoli in 1993 [14] . Void spaces are observed between the cancer nest and the surrounding stroma, and the tumor cell clumps appear to be suspended in the transparent and structureless space. Tumor cells show reverse polarity, also called an inside-out growth pattern, whereby the ductal surface (stromal surface) faces outwards and not inwards towards the cancer nest [15] . IMPC is characterized by prominent lymphovascular invasion and lymph node metastases and is often reported to have a poor prognosis [16] [17] [18] . In other words, the PMC subtype has a favorable prognosis whereas the IMPC subtype has a poor prognosis as compared to the normal invasive breast cancer.
Although MUMPC resembles PMC from a histopathological viewpoint in showing clumps of atypical cells suspended in mucous lakes, the papillary growth pattern exhibited by these atypical cells differentiates MUMPC from PMC. MUMPC also follows an IMPC-like clinical course with micropapillary cancer cells leading to lymphovascular invasion and lymph node metastases [6] . In the NCCN guidelines, PMC is regarded as "a histological type with a favorable prognosis" in a uniform manner, and "treatment for a histological type with a favorable prognosis" is recommended [19] . However, the treatment of MUMPC resembles that of IMPC. Consequently, careful attention is required to differentiate between PMC and MUMPC as they differ in their malignant potentials.
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